Search Results - "Sylvia, Giard"

Use of [18 F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [18 F]-FDG PET-predicted non-responders (AVATAXHER): an open-label, randomised phase 2 trial by Coudert, Bruno, Dr, Pierga, Jean-Yves, Prof, Mouret-Reynier, Marie-Ange, MD, Kerrou, Kaldoun, MD, Ferrero, Jean-Marc, Prof, Petit, Thierry, Prof, Kerbrat, Pierre, MD, Dupré, Pierre-François, MD, Bachelot, Thomas, MD, Gabelle, Philippe, MD, Giard, Sylvia, MD, Coeffic, David, MD, Bougnoux, Philippe, Prof, Prevost, Jean-Briac, MD, Paintaud, Gilles, Prof, Thibault, Gilles, Prof, Hernandez, Juana, MD, Coudert, Mathieu, MSc, Arnould, Laurent, MD, Berriolo-Riedinger, Alina, MD

“…Summary Background An effective and well tolerated treatment is needed for patients with early HER2-positive breast cancer who do not achieve a pathological…”
Get full text

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy for Advanced Breast Cancer: Results of Ganglion Sentinelle et Chimiothérapie Neoadjuvante, a French Prospective Multicentric Study by CLASSE, Jean-Marc, BORDES, Virginie, CAMPION, Loic, MIGNOTTE, Herve, DRAVET, Francois, LEVEQUE, Jean, SAGAN, Christine, FRANCOIS DUPRE, Pierre, BODY, Gilles, GIARD, Sylvia

“…To determine the detection rate, the false-negative rate, and the accuracy of sentinel lymph node (SLN) detection after neoadjuvant chemotherapy (NAC) for…”
Get full text

Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: The French Sentimag feasibility trial by Houpeau, Jean-Louis, Chauvet, Marie-Pierre, Guillemin, François, Bendavid-Athias, Cécile, Charitansky, Hélène, Kramar, Andrew, Giard, Sylvia

“…Background and Objectives The French Sentimag feasibility trial evaluated a new method for the localization of breast cancer sentinel lymph node (SLN) using…”
Get full text

Lymph node positivity in different early breast carcinoma phenotypes: a predictive model by Houvenaeghel, Gilles, Lambaudie, Eric, Classe, Jean-Marc, Mazouni, Chafika, Giard, Sylvia, Cohen, Monique, Faure, Christelle, Charitansky, Hélène, Rouzier, Roman, Daraï, Emile, Hudry, Delphine, Azuar, Pierre, Villet, Richard, Gimbergues, Pierre, Tunon de Lara, Christine, Martino, Marc, Fraisse, Jean, Dravet, François, Chauvet, Marie Pierre, Boher, Jean Marie

“…A strong correlation between breast cancer (BC) molecular subtypes and axillary status has been shown. It would be useful to predict the probability of lymph…”
Get full text

Therapeutic escalation – De-escalation: Data from 15.508 early breast cancer treated with upfront surgery and sentinel lymph node biopsy (SLNB) by Houvenaeghel, Gilles, MD, Lambaudie, Eric, PhD, Cohen, Monique, MD, Classe, Jean-Marc, PhD, Reyal, Fabien, MD, Garbay, Jean-Rémy, MD, Giard, Sylvia, MD, Chopin, Nicolas, MD, Martinez, Alejandra, MD, Rouzier, Roman, PhD, Daraï, Emile, MD, Colombo, Pierre Emmanuel, PhD, Coutant, Charles, PhD, Gimbergues, Pierre, PhD, Azuar, Pierre, MD, Villet, Richard, MD, Tunon de Lara, Christine, MD, Barranger, Emmanuel, MD, Sabiani, Laura, MD, Goncalves, Anthony, PhD

“…Abstract Introduction The aim of this study was to examine changes in therapeutic practices for early breast cancer T0-2 N0 managed by upfront surgery and…”
Get full text

Messenger RNA Expression of Leptin and Leptin Receptors and their Prognostic Value in 322 Human Primary Breast Cancers by REVILLION, Francoise, CHARLIER, Madia, LHOTELLIER, Valérie, HORNEZ, Louis, GIARD, Sylvia, BARANZELLI, Marie-Christine, DJIANE, Jean, PEYRAT, Jean-Philippe

“…Purpose: Leptin and obesity are clearly related, and obesity is associated with an increased risk of breast cancer. We therefore measured the expression of…”
Get full text

Prevention of surgical site infection after breast cancer surgery by targeted prophylaxis antibiotic in patients at high risk of surgical site infection by Nicolas, Penel, Yazdan, Yazdanpanah, Marie-Pierre, Chauvet, Stéphanie, Clisant, Sylvia, Giard, Jean-Charles, Neu, Danièle, Lefebvre, Charles, Fournier, Jacques, Bonneterre

“…Objective We previously showed that previous chemotherapy and immediate breast reconstruction were associated with an increased risk of surgical site infection…”
Get full text

Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification by Ng, Charlotte K Y, Martelotto, Luciano G, Gauthier, Arnaud, Wen, Huei-Chi, Piscuoglio, Salvatore, Lim, Raymond S, Cowell, Catherine F, Wilkerson, Paul M, Wai, Patty, Rodrigues, Daniel N, Arnould, Laurent, Geyer, Felipe C, Bromberg, Silvio E, Lacroix-Triki, Magali, Penault-Llorca, Frederique, Giard, Sylvia, Sastre-Garau, Xavier, Natrajan, Rachael, Norton, Larry, Cottu, Paul H, Weigelt, Britta, Vincent-Salomon, Anne, Reis-Filho, Jorge S

“…HER2 is overexpressed and amplified in approximately 15% of invasive breast cancers, and is the molecular target and predictive marker of response to anti-HER2…”
Get full text

Rates of Neoadjuvant Chemotherapy and Oncoplastic Surgery for Breast Cancer Surgery: A French National Survey by Clough, Krishna B., Acosta-Marín, Victor, Nos, Claude, Alran, Séverine, Rouanet, Philippe, Garbay, Jean-Rémi, Giard, Sylvia, Verhaeghe, Jean-Luc, Houvenaeghel, Gilles, Flipo, Bernard, Dauplat, Jacques, Dorangeon, Pierre Hervé, Classe, Jean-Marc, Rouzier, Roman, Bonnier, Pascal

“…Background The current retrospective study was intended to obtain up-to-date and comprehensive data on surgical practice for breast cancer throughout France,…”
Get full text

Value of a gene signature assay in patients with early breast cancer and intermediate risk: a single institution retrospective study by Bonneterre, Jacques, Prat, Aleix, Galván, Patricia, Morel, Pascale, Giard, Sylvia

“…Purpose In daily clinical practice, the indication for adjuvant chemotherapy (CT) is relatively easy to make in patients with early hormone-receptor-positive…”
Get full text

Breast cancer in young women: Pathologic features and molecular phenotype by Sabiani, Laura, Houvenaeghel, Gilles, Heinemann, Mellie, Reyal, Fabien, Classe, Jean Marc, Cohen, Monique, Garbay, Jean Rémy, Giard, Sylvia, Charitansky, Hélène, Chopin, Nicolas, Rouzier, Roman, Daraï, Emile, Coutant, Charles, Azuar, Pierre, Gimbergues, Pierre, Villet, Richard, Tunon de Lara, Christine, Lambaudie, Eric

“…Abstract Purpose Controversy exists about the prognosis of breast cancer in young women. Our objective was to describe clinicopathological and prognostic…”
Get full text

Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study by de Nonneville, Alexandre, Gonçalves, Anthony, Zemmour, Christophe, Classe, Jean M., Cohen, Monique, Lambaudie, Eric, Reyal, Fabien, Scherer, Christophe, Muracciole, Xavier, Colombo, Pierre E., Giard, Sylvia, Rouzier, Roman, Villet, Richard, Chopin, Nicolas, Darai, Emile, Garbay, Jean R., Gimbergues, Pierre, Sabiani, Laura, Coutant, Charles, Sabatier, Renaud, Bertucci, François, Boher, Jean M., Houvenaeghel, Gilles

“…Purpose Benefit of adjuvant trastuzumab-based chemotherapy for node-positive and/or >1 cm human epidermal growth factor receptor 2-positive (HER2+) breast…”
Get full text

Benefit of adjuvant chemotherapy and/or trastuzumab in T1ab node-negative human epidermal growth factor receptor 2–positive breast carcinomas: Results of a national multi-institutional study by de Nonneville, Alexandre, Goncalves, Anthony, Zemmour, Christophe, Classe, Jean-Marc, Cohen, Monique, Lambaudie, Eric, Reyal, Fabien, Giard, Sylvia, Rouzier, Roman, Villet, Richard, Boher, Jean-Marie, Houvenaeghel, Gilles

“…Abstract only…”
Get full text

Upper outer boundaries of the axillary dissection. Result of the SENTIBRAS protocol: Multicentric protocol using axillary reverse mapping in breast cancer patients requiring axillary dissection by Nos, Claude, MD, Clough, Krishna B., MD, Bonnier, Pascal, MD Ph D, Lasry, Serge, MD, Le Bouedec, Guillaume, MD, Flipo, Bernard, MD, Classe, Jean-marc, Ph D, Missana, Marie-christine, MD, Doridot, Virginie, MD, Giard, Sylvia, MD, Charitansky, Hélène, MD, Charles-Nelson, Anaïs, DM, Ngo, Charlotte, MD, Bats, Anne-Sophie, MD PhD

“…Abstract Background Two thirds of node-positive breast cancer patients have limited pN1 disease and could benefit from a less extensive axillary lymph node…”
Get full text

Prognostic value of isolated tumor cells and micrometastases of lymph nodes in early-stage breast cancer: A French sentinel node multicenter cohort study by Houvenaeghel, Gilles, Classe, Jean-Marc, Garbay, Jean-Rémy, Giard, Sylvia, Cohen, Monique, Faure, Christelle, Hélène, Charytensky, Belichard, Catherine, Uzan, Serge, Hudry, Delphine, Azuar, Pierre, Villet, Richard, Penault Llorca, Frédérique, Tunon de Lara, Christine, Goncalves, Anthony, Esterni, Benjamin

“…Abstract To define the prognostic value of isolated tumor cells (ITC), micrometastases (pN1mi) and macrometastases in early stage breast cancer (ESBC). We…”
Get full text

Partial breast irradiation as sole therapy for low risk breast carcinoma: Early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study by Belkacémi, Yazid, Chauvet, Marie-Pierre, Giard, Sylvia, Villette, Sylviane, Lacornerie, Thomas, Bonodeau, François, Baranzelli, Marie-Christine, Bonneterre, Jacques, Lartigau, Eric

“…Abstract Purpose The MammoSite is a device that was developed with the goal of making breast-conserving surgery (BCT) more widely available. Our objective was…”
Get full text

Eligibility criteria for intraoperative radiotherapy for breast cancer: study employing 12,025 patients treated in two cohorts by Ziouèche-Mottet, Amira, Houvenaeghel, Gilles, Classe, Jean Marc, Garbay, Jean Rémi, Giard, Sylvia, Charitansky, Hélène, Cohen, Monique, Belichard, Catherine, Faure, Christelle, Chéreau Ewald, Elisabeth, Hudry, Delphine, Azuar, Pierre, Villet, Richard, Gimbergues, Pierre, Tunon de Lara, Christine, Tallet, Agnès, Bannier, Marie, Minsat, Mathieu, Lambaudie, Eric, Resbeut, Michel

“…We wished to estimate the proportion of patients with breast cancer eligible for an exclusive targeted intraoperative radiotherapy (TARGIT) and to evaluate…”
Get full text

Non sentinel node involvement prediction for sentinel node micrometastases in breast cancer: Nomogram validation and comparison with other models by Houvenaeghel, Gilles, Bannier, Marie, Nos, Claude, Giard, Sylvia, Mignotte, Herve, Jacquemier, Jocelyne, Martino, Marc, Esterni, Benjamin, Belichard, Catherine, Classe, Jean-Marc, Tunon de Lara, Christine, Cohen, Monique, Payan, Raoul, Blanchot, Jerome, Rouanet, Philippe, Penault-Llorca, Frederique, Bonnier, Pascal, Fournet, Sandrine, Agostini, Aubert, Marchal, Frederique, Garbay, Jean-Remi

“…Abstract Purpose The risk of non sentinel node (NSN) involvement varies in function of the characteristics of sentinel nodes (SN) and primary tumor. Our aim…”
Get full text

A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis by Houvenaeghel, G, Nos, C, Giard, S, Mignotte, H, Esterni, B, Jacquemier, J, Buttarelli, M, Classe, J.-M, Cohen, M, Rouanet, P, Penault Llorca, F, Bonnier, P, Marchal, F, Garbay, J.-R, Fraisse, J, Martel, P, Fondrinier, E, Tunon de Lara, C, Rodier, J.-F

“…Abstract Purpose Predictive factors of non-sentinel lymph node (NSN) involvement at axillary lymph node dissection (ALND) have been studied in the case of…”
Get full text

Characteristics and clinical outcome of T1 breast cancer: A national multicenter retrospective cohort study by Gonçalves, Anthony, Classe, Jean-Marc, Garbay, Jean-Remy, Giard, Sylvia, Helene, Charytansky, Cohen, Monique, Belichard, Monique, Faure, Christelle, Uzan, Serge, Hudry, Delphine, Azuar, Pierre, Villet, Richard, Gimbergues, Pierre, Tunon de Lara, Christine, Esterni, Benjamin, Houvenaeghel, Gilles

“…Abstract only 566 Background: T1N0M0 breast cancer (BC) are generally considered as carrying good prognosis and cancer-specific survival rates after 5 to 10…”
Get full text